India to Kyrgyzstan: Ledipasvir Export Trade Route
India has recorded 1 verified shipments of Ledipasvir exported to Kyrgyzstan, representing a combined trade value of $88.1K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $88.1K USD. The leading Indian exporter is HETERO LABS LIMITED, which accounts for 100% of total export value with 1 shipments worth $88.1K USD. On the buying side, MS is the largest importer in Kyrgyzstan with $88.1K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kyrgyzstan Ledipasvir corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $88.1K USD. The route is dominated by HETERO LABS LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ledipasvir manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $88.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 12.6%, placing it at rank #15 among India's top ledipasvir export destinations globally.
On the import side, key buyers of Indian ledipasvir in Kyrgyzstan include MS. MS is the single largest importer with 1 shipments valued at $88.1K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#15
- Annual growth+12.6%
- Demand growth+11.2%
- Regulatory ease70/100
Top 10 Indian Ledipasvir Exporters to Kyrgyzstan
Showing top 10 of 1 Indian suppliers exporting Ledipasvir to Kyrgyzstan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED Avg $88.1K per shipment | 1 | $88.1K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting ledipasvir to Kyrgyzstan, ranked by total trade value. The listed exporters are: HETERO LABS LIMITED. HETERO LABS LIMITED is the dominant supplier with 1 shipments worth $88.1K USD, giving it a 100% market share.
Top 10 Ledipasvir Importers in Kyrgyzstan
Showing top 10 of 1 known buyers in Kyrgyzstan receiving Ledipasvir shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ledipasvir in Kyrgyzstan include MS. The largest importer is MS, accounting for $88.1K USD across 1 shipments — representing 100% of all ledipasvir imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MS | 1 | $88.1K | 100.0% |
Top 10 Ledipasvir Formulations Imported by Kyrgyzstan
Showing top 10 of 1 product formulations shipped on the India to Kyrgyzstan Ledipasvir route, ranked by trade value
Kyrgyzstan imports a wide range of ledipasvir formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LISOF LEDIPASVIR 90MG + SOFOSBUVIR 400MG — accounts for $88.1K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LISOF LEDIPASVIR 90MG + SOFOSBUVIR 400MG | 1 | $88.1K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 1 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's ledipasvir exports to Kyrgyzstan are driven primarily by a handful of large-scale manufacturers. HETERO LABS LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Kyrgyzstan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — HETERO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $88.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
On the buying side, MS is the largest importer with 1 shipments worth $88.1K USD — representing 100% of all ledipasvir imports from India on this route.
Route Statistics
- Trade Volume
- $88.1K
- Avg. Shipment
- $88.1K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~27 days
- Annual Growth
- +12.6%
Related Analysis
Other Ledipasvir Routes
Unlock the Full India to Kyrgyzstan Ledipasvir Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — India to Kyrgyzstan Ledipasvir Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ledipasvir to Kyrgyzstan?
The leading Indian exporters of Ledipasvir to Kyrgyzstan are HETERO LABS LIMITED. HETERO LABS LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Ledipasvir exports from India to Kyrgyzstan?
India exports Ledipasvir to Kyrgyzstan worth approximately $88.1K USD across 1 recorded shipments. The average value per shipment is $88.1K USD.
Q Which ports does India use to ship Ledipasvir to Kyrgyzstan?
The most active port of origin is SAHAR AIR with 1 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Kyrgyzstan for Ledipasvir?
The average transit time for Ledipasvir shipments from India to Kyrgyzstan is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Kyrgyzstan Ledipasvir trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.6% with demand growth tracking at 11.2%. The route is ranked #15 among India's top Ledipasvir export destinations globally.
Q How many suppliers are active on the India to Kyrgyzstan Ledipasvir route?
There are currently 1 active Indian suppliers exporting Ledipasvir to Kyrgyzstan. The market is moderately concentrated with HETERO LABS LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Ledipasvir from India in Kyrgyzstan?
The leading importers of Indian Ledipasvir in Kyrgyzstan include MS. MS is the largest buyer with 1 shipments worth $88.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kyrgyzstan export trade corridor identified from Indian Customs (DGFT) records for Ledipasvir.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Kyrgyzstan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists